Search or ask a question

Who sells neuronal?

Trinucleotide repeat expansion

Neurodegeneration

Polyglutamine tract

Answers from top 2 papers

PDF

Open Access

More filters

Papers (2)	Insight
Journal Article•DOI Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. Lenore K. Beitel, Thomas C. Scanlon, Bruce Gottlieb, Mark Trifiro - Show less +3 more 01 Jan 2005-Neurotoxicity Research 22 Citations	These studies suggest a number of potential treatments for restoring neuronal function.
Open access•Book Chapter•DOI Compartmentalized Neuronal Cultures Armine Darbinyan, Paul D. Pozniak, Nune Darbinian, Martyn K. White, Kamel Khalili - Show less +4 more 01 Jan 2013-Methods of Molecular Biology 8 Citations	This device provides an opportunity to orient neuronal outgrowth and spatially isolate neuronal processes from neuronal bodies.

My columns

Related Questions

How is neuroplasticity affected by marketing?5 answersNeuroplasticity is not directly addressed in the provided abstracts.

What has NeuroSky invented?5 answersNeuroSky has invented a consumer brain-computer interface (BCI) called the NeuroSky MindSet. This BCI allows users to control games and other applications using their powers of concentration and relaxation. It uses a NeuroSky biosensor to detect brainwaves, such as voluntary blinks and attention, to form a brain-computer interface. The NeuroSky MindWave mobile is a single-channel device that can be used for data acquisition in EEG signals. The company has also developed a control tool using the NeuroSky Mindwave headset, which detects brainwaves to create a BCI for disabled individuals. Additionally, NeuroSky has proposed a brain sense controlled wireless robot that can be used to support paralyzed individuals in moving and controlling home appliances.

What is neuromarketing introduction?5 answersNeuromarketing is a field that combines neuroscience and marketing to gain insights into consumer behavior and preferences. It focuses on understanding the subconscious mind of consumers and predicting their behavior. The term was first coined in 2002 by Professor Ale Smidts, and companies were already adopting neuromarketing techniques before that. Neuromarketing offers unique and complementary insights to traditional marketing methods. It uses scientific methods, such as functional Magnetic Resonance Imaging (fMRI), to understand how consumers respond to marketing campaigns. The field of neuromarketing is still relatively new, and there is a need for more empirical research to address challenges related to reliability, validity, and generalizability. It has the potential to significantly improve the effectiveness of advertising and marketing messages by directly probing consumers' minds without relying on their conscious participation.

How much does talent neuron cost?7 answers

How to make a neuron out of candy?6 answers

Who came up with Neuron Doctrine?7 answers

See what other people are reading

What studies demonstrate effects of a botanical active on DEGs?

Several studies have demonstrated the effects of botanical actives on neurodegenerative disorders (NDDs) through various mechanisms. These botanical compounds have shown potential in alleviating symptoms of NDDs by targeting molecular pathways such as antioxidant, anti-inflammatory, antiapoptotic, and neurotrophic activities. Additionally, the extracts of specific plants have been found to ameliorate Alzheimer's disease symptoms through mechanisms like acetylcholinesterase inhibition, modification of monoamines, antiamyloid aggregation effect, and antioxidant activity. Furthermore, nutraceuticals containing herbal extracts have been studied for their effects on skin health and antioxidant status in post-menopausal women, showing improvements in skin parameters and antioxidant levels without adverse effects. These studies collectively highlight the potential of botanical actives in targeting diverse molecular pathways to address neurodegenerative disorders and skin aging concerns.What phophostatses remocing Y531 off Fyn\?

Phosphorylation of tyrosine-531 (Y531) on the Fyn protein plays a crucial role in its regulation. While Src family tyrosine kinases, particularly Fyn, are involved in phosphorylating Y531 on Fyn, the removal of this phosphorylation is mediated by phosphatases. However, the specific phosphatases responsible for dephosphorylating Y531 on Fyn are not explicitly mentioned in the provided contexts. It is known that tyrosine phosphatases, such as PTPN1 and PTPN2, can dephosphorylate tyrosine residues on various proteins, but their direct involvement in removing the phosphate group from Y531 on Fyn is not detailed in the given abstracts. Further research may be needed to identify the exact phosphatases involved in the dephosphorylation of Y531 on the Fyn protein.What phophostatses remocing Y531 off Fyn?

Phosphorylation of tyrosine-531 (Y531) on the Fyn protein is a crucial regulatory event. The removal of phosphate groups from Y531 on Fyn is carried out by phosphatases. While the specific phosphatases responsible for dephosphorylating Y531 on Fyn are not explicitly mentioned in the provided contexts, it is known that tyrosine phosphatases play a key role in counteracting the actions of tyrosine kinases like Fyn. The balance between kinases and phosphatases is essential for proper cellular signaling and function.1.How does NAD metabolism change in neurons with age?

Nicotinamide adenine dinucleotide (NAD+) metabolism undergoes significant changes in neurons with age. As individuals age, there is a decline in NAD levels, which has been associated with various age-related diseases. This decrease in NAD levels is linked to the development of neurodegenerative diseases, as seen in Alzheimer's disease models where free NADH concentrations decrease with age, particularly in neurons from old mice and Alzheimer's disease models. The decline in NAD levels contributes to impaired energy metabolism in neurons, leading to deficits in ATP production and mitochondrial function, ultimately impacting neuronal health and increasing the risk of neurodegeneration. Strategies targeting NAD metabolism have shown promise in ameliorating age-associated pathologies and extending health span, highlighting the importance of NAD in neuronal aging.What biological factors/mechanisms may underlie the development and maintanance of PTSD?

The development and maintenance of PTSD may involve various biological factors and mechanisms. Neurobiological models suggest that PTSD symptoms can be influenced by neural mechanisms involving fear-related brain structures like the hippocampus, amygdala, and prefrontal cortex, which can undergo time-dependent changes. Epigenetic changes at the genomic and epigenomic level have been proposed to play a role in the susceptibility to PTSD after exposure to traumatic stress. Inflammation, particularly neuroinflammation, has been identified as a putative susceptibility factor for PTSD, with elevated levels of certain cytokines in the brain of susceptible individuals. Furthermore, biomarkers associated with neurodegenerative disorders, such as cerebral cortical thinning and immune-inflammatory alterations, have been linked to PTSD, potentially shedding light on the pathophysiological mechanisms connecting these conditions. Additionally, aberrant susceptibility of emotion- and fear-related neurocircuits, including the amygdala, prefrontal cortex, and hippocampus, may contribute to the development and retention of PTSD symptoms.What are the potential therapeutic interventions targeting the circadian clock in the treatment of Alzheimer's disease?

Therapeutic interventions targeting the circadian clock in Alzheimer's disease (AD) treatment include time-restricted feeding (TRF), restoration of sleep and circadian rhythms, dietary interventions like TRF and exogenous glucagon-like peptide-1 (GLP-1), and clock-enhancing modulators such as Nobiletin (NOB). Music therapy and rhythmic-based interventions have also shown promise in improving quality of life for AD patients by influencing circadian rhythmicity. TRF without caloric restriction has been found to reduce amyloid deposition, improve sleep, and normalize gene transcription in AD mouse models. Additionally, GLP-1 and TRF treatments improved circadian rhythm, metabolic homeostasis, and cognitive function in transgenic AD mice. NOB treatment alleviated β-amyloid burden, improved cognitive function, and suppressed neuroinflammation in AD model mice. Music therapy may offer non-pharmacological circadian-based interventions to target AD pathogenesis and enhance clinical treatment.Is craniocervical instability dangerous?

Craniocervical instability can indeed be dangerous, as it may lead to severe consequences due to compression of vascular and neural structures at the craniocervical junction. Patients with the oculoauriculovertebral spectrum (OAVS) may exhibit craniocervical instability, which can result in morbidity and mortality, especially when manipulating an unstable spine. In Down syndrome (DS) patients, approximately one-third develop craniovertebral junction (CVJ) instability, putting them at an increased risk of spinal cord injury. Pathologies in the craniovertebral junction, such as chordoma and chondrosarcoma, can predispose individuals to joint instability, necessitating careful clinical and radiological assessment to predict postoperative instability and the need for fixation. Therefore, craniocervical instability poses significant risks and requires appropriate evaluation and management to prevent adverse outcomes.What are the findings on the endocannabinoid Palmitoylethanolamide in humans?

Palmitoylethanolamide (PEA) has shown promising findings in humans. Studies suggest that PEA supplementation can reduce negative psychotic and manic symptoms in psychosis patients, with increased plasma and CNS levels observed as a potential compensatory response to illness severity. Additionally, PEA has demonstrated clinically relevant analgesic properties, acting on both peripheral and central mechanisms, as well as in pain modulation. In the context of long COVID, PEA treatment has shown potential efficacy in improving symptoms and functional status, particularly in patients with prolonged post-infection issues. Furthermore, PEA supplementation has been associated with reducing fatigue and cognitive impairment, improving global executive function, working memory, and language deficits in individuals with neurocognitive disorders. These findings highlight the diverse therapeutic potential of PEA in various health conditions.What is the difference between amyloid plaques and tau proteins in Alzheimers?

Amyloid plaques and tau proteins are distinct hallmarks of Alzheimer's disease (AD). Amyloid plaques are extracellular deposits primarily composed of amyloid-β (Aβ) protein, while tau proteins form intracellular neurofibrillary tangles (NFTs) due to abnormal hyperphosphorylation. Studies suggest that the number of NFTs correlates with the severity of dementia in AD patients. While Aβ plaques and tau pathology are defining features of AD, the interaction between these two proteins is crucial in the disease's progression. The synergistic effects of Aβ and tau contribute to cognitive dysfunction in AD patients. Furthermore, the phosphorylated tau epitopes are considered biomarkers of tau pathology, but their association with Aβ plaques and tau neurofibrillary tangles remains unclear. Understanding the roles of both amyloid plaques and tau proteins is essential for developing effective interventions against AD.How to engineering Beta-Amyloid for Alzheimer disease?

Engineering Beta-Amyloid for Alzheimer's disease involves exploring novel structures like two-dimensional covalent organic frameworks (COFs), MBenes such as Cd2B, Mo2B, Cu2B, and Ta2B, and stable alginate microbeads containing amyloid-producing cells. These structures have shown potential in preventing Beta-Amyloid aggregation, destabilizing amyloid structures, and providing a platform for studying chronic Aβ production. The use of engineered COFs with amine functional groups and high contact areas can inhibit Beta-Amyloid aggregation and enhance diffusivity through the blood-brain barrier. Similarly, MBenes, especially Cd2B, have demonstrated effectiveness in destabilizing amyloid-β structures, potentially preventing accumulation. Additionally, alginate microbeads encapsulating amyloid-secreting cells offer a stable platform for sustained Aβ release, enabling the modeling of Alzheimer's disease progression in vitro and in vivo.How do gut microbes use formaldehyde oxidation-I and formaldehyde assimilation-II pathways to decrease formaldehyde levels in neuropathy?

Gut microbes utilize formaldehyde oxidation-I and formaldehyde assimilation-II pathways to reduce formaldehyde levels in neuropathy. Formaldehyde, a cytotoxic compound in methanol metabolism, is detoxified by trapping with cofactors like glutathione and tetrahydrofolate before oxidation to CO2. In the formaldehyde assimilation pathways, yeasts use the xylulose monophosphate pathway, while bacteria employ the ribulose monophosphate pathway to trap formaldehyde with sugar phosphates. These pathways aid in formaldehyde detoxification and energy production. The gut microbiota's role in neurodegenerative diseases like neuropathy involves interactions with formaldehyde metabolism pathways, potentially influencing neurotoxic outcomes. Understanding how gut microbes modulate formaldehyde levels through these pathways is crucial in deciphering their impact on neuropathy and other neurological disorders.